tiprankstipranks
Trending News
More News >
Evofem Biosciences (EVFM)
OTHER OTC:EVFM
US Market

Evofem Biosciences (EVFM) Financial Statements

Compare
1,207 Followers

Evofem Biosciences Financial Overview

Evofem Biosciences's market cap is currently $1.11M. The company's EPS TTM is $0.022; its P/E ratio is 3.00; Evofem Biosciences is scheduled to report earnings on February 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Mar 23Dec 21
Income Statement
Total Revenue$ 20.18M$ 19.36M$ 18.22M$ 16.84M$ 8.24M
Gross Profit$ 15.07M$ 15.53M$ 11.71M$ 12.42M$ 4.19M
Operating Income$ 1.44M$ -7.68M$ -17.85M$ -84.12M$ -166.80M
EBITDA$ 2.06M$ -6.92M$ -16.07M$ -82.08M$ -165.78M
Net Income$ 391.00K$ -8.86M$ 52.98M$ -76.70M$ -205.19M
Balance Sheet
Cash & Short-Term Investments$ 578.00K$ 741.00K$ 580.00K$ 2.77M$ 7.73M
Total Assets$ 20.27M$ 23.79M$ 10.55M$ 25.16M$ 42.51M
Total Debt$ 65.87M$ 45.97M$ 43.37M$ 71.13M$ 115.68M
Net Debt$ 65.29M$ 45.97M$ 43.37M$ 68.36M$ 107.95M
Total Liabilities$ 89.71M$ 95.05M$ 77.06M$ 96.96M$ 142.09M
Stockholders' Equity$ -69.44M$ -71.26M$ -66.51M$ -71.80M$ -99.58M
Cash Flow
Free Cash Flow$ -2.00M$ -3.90M$ -8.97M$ -70.75M$ -149.61M
Operating Cash Flow$ -1.99M$ -3.88M$ -8.97M$ -70.41M$ -146.67M
Investing Cash Flow$ -62.00K$ -569.00K$ -4.00K$ -341.00K$ -2.69M
Financing Cash Flow$ 1.89M$ 4.62M$ 4.78M$ 61.94M$ 90.69M
Currency in USD

Evofem Biosciences Earnings and Revenue History

Evofem Biosciences Debt to Assets

Evofem Biosciences Cash Flow

Evofem Biosciences Forecast EPS vs Actual EPS